Edition:
United States

McKesson Corp (MCK)

MCK on New York Consolidated

133.83USD
17 Jun 2019
Change (% chg)

$0.70 (+0.53%)
Prev Close
$133.13
Open
$133.84
Day's High
$134.09
Day's Low
$132.20
Volume
950,022
Avg. Vol
1,428,914
52-wk High
$149.43
52-wk Low
$106.11

Latest Key Developments (Source: Significant Developments)

Mckesson Reports Q4 2019 Results
Wednesday, 8 May 2019 07:00am EDT 

May 8 (Reuters) - McKesson Corp ::MCKESSON REPORTS FISCAL 2019 FOURTH-QUARTER AND FULL-YEAR RESULTS.SEES FY 2020 ADJUSTED EARNINGS PER SHARE $13.85 TO $14.45.Q4 ADJUSTED EARNINGS PER SHARE $3.69.Q4 GAAP LOSS PER SHARE $4.17 FROM CONTINUING OPERATIONS.Q4 REVENUE $52.4 BILLION VERSUS REFINITIV IBES ESTIMATE OF $53.15 BILLION.Q4 EARNINGS PER SHARE ESTIMATE $3.66 -- REFINITIV IBES DATA.RENEWED PHARMACEUTICAL DISTRIBUTION RELATIONSHIP WITH CVS HEALTH THROUGH JUNE 2023.ANTICIPATES ANNUAL PRE-TAX SAVINGS OF APPROXIMATELY $400 MILLION TO $500 MILLION, THAT WILL BE SUBSTANTIALLY REALIZED BY END OF FISCAL 2021.FY2020 EARNINGS PER SHARE VIEW $14.14 -- REFINITIV IBES DATA.MCKESSON - ANTICIPATES IT WILL GENERATE ABOUT $400 MILLION TO $500 MILLION IN ANNUAL PRE-TAX SAVINGS THAT WILL BE SUBSTANTIALLY REALIZED BY END OF FISCAL 2021.MCKESSON SEES LOW- TO MID-SINGLE DIGIT PERCENT REVEGROWTH AND FLAT TO LOW-SINGLE DIGIT PERCENT ADJUSTED INCOME FROM OPERATIONS DECLINE IN FISCAL 2020.  Full Article

Mckesson Settles With West Virginia On Opioid Order Monitoring & Reporting
Thursday, 2 May 2019 12:15pm EDT 

May 2 (Reuters) - McKesson Corp ::MCKESSON REACHES SETTLEMENT WITH STATE OF WEST VIRGINIA ON OPIOID ORDER MONITORING AND REPORTING.MCKESSON CORP - MCKESSON WILL PAY $14.5 MILLION TO WEST VIRGINIA THIS YEAR AND AN ADDITIONAL $4.5 MILLION PER YEAR FOR NEXT FIVE YEARS.  Full Article

FDA Says Issued Its First Warning Letter Under The Drug Supply Chain Security Act To Mckesson
Tuesday, 12 Feb 2019 10:08am EST 

Feb 12 (Reuters) - U.S. Food and Drug Administration::FDA - ISSUED ITS FIRST WARNING LETTER UNDER THE DRUG SUPPLY CHAIN SECURITY ACT (DSCSA) TO MCKESSON.FDA - ISSUED FIRST WARNING LETTER UNDER DSCSA TO MCKESSON FOR VIOLATIONS HIGHLIGHTED BY A TAMPERING INCIDENT THAT INVOLVED OPIOID MEDICATIONS.FDA - WARNING LETTER UNDER DSCSA TO MCKESSON OUTLINES VIOLATIONS OBSERVED DURING INSPECTIONS THAT TOOK PLACE THIS PAST SUMMER.  Full Article

McKesson Reports Q3 Adj EPS Of $3.40
Thursday, 31 Jan 2019 04:10pm EST 

Jan 31 (Reuters) - McKesson Corp ::MCKESSON REPORTS FISCAL 2019 THIRD-QUARTER RESULTS.Q3 ADJUSTED EARNINGS PER SHARE $3.40.Q3 GAAP EARNINGS PER SHARE $2.41 FROM CONTINUING OPERATIONS.Q3 REVENUE $56.2 BILLION VERSUS REFINITIV IBES ESTIMATE OF $55.1 BILLION.Q3 EARNINGS PER SHARE ESTIMATE $3.16 -- REFINITIV IBES DATA.SEES FY 2019 ADJUSTED EARNINGS PER SHARE $13.45 TO $13.65.FY2019 EARNINGS PER SHARE VIEW $13.41 -- REFINITIV IBES DATA.  Full Article

EKF Diagnostics Says Sales Of Mckesson Consult HB Analyzer Expected Next Month
Tuesday, 22 Jan 2019 02:00am EST 

Jan 22 (Reuters) - EKF Diagnostics Holdings PLC ::EKF DIAGNOSTICS - SALES OF MCKESSON CONSULT HB ANALYZER ARE EXPECTED NEXT MONTH FOLLOWING FULL LAUNCH OF PRODUCT IN US.EKF DIAGNOSTICS HOLDINGS PLC - FULL LAUNCH OF MCKESSON CONSULT HB ANALYZER IN US IS SCHEDULED FOR 6 FEBRUARY 2019.EKF DIAGNOSTICS - SALES OF MCKESSON CONSULT HB ANALYZER EXPECTED TO CONTRIBUTE TO REVENUE GROWTH IN FINANCIAL YEAR ENDING 31 DEC 2019 & ONWARDS.  Full Article

Rite Aid and Mckesson agree to key terms for pharmaceutical purchasing and distribution
Wednesday, 19 Dec 2018 04:15pm EST 

Dec 19 (Reuters) - McKesson Corp ::RITE AID AND MCKESSON AGREE TO KEY TERMS FOR PHARMACEUTICAL PURCHASING AND DISTRIBUTION.RITE AID CORP - RITE AID PARTNERSHIP WITH MCKESSON TO CONTINUE FOR 10 ADDITIONAL YEARS THROUGH MARCH 2029.RITE AID CORP - MCKESSON TO CONTINUE PROVIDING RITE AID WITH SOURCING AND DIRECT-TO-STORE DELIVERY FOR BRAND AND GENERIC PHARMACEUTICAL PRODUCTS.RITE AID CORP - TERMS PROVIDE RITE AID WITH COMPETITIVE DRUG PRICING AND OPERATIONAL FLEXIBILITY.RITE AID CORP - RITE AID PARTNERSHIP WITH MCKESSON TO CONTINUE FOR 10 ADDITIONAL YEARS THROUGH MARCH 2029.  Full Article

Mckesson Q1 Adjusted Earnings Per Share $2.90
Thursday, 26 Jul 2018 07:00am EDT 

McKesson Corp ::BOARD OF DIRECTORS APPROVED RAISING QUARTERLY DIVIDEND BY 15% FROM 34 CENTS TO 39 CENTS PER SHARE.MCKESSON REPORTS FISCAL 2019 FIRST-QUARTER RESULTS.SEES FY 2019 ADJUSTED EARNINGS PER SHARE $13.00 TO $13.80.Q1 ADJUSTED EARNINGS PER SHARE $2.90.Q1 GAAP LOSS PER SHARE $0.69 FROM CONTINUING OPERATIONS.Q1 REVENUE $52.6 BILLION VERSUS I/B/E/S VIEW $52.9 BILLION.Q1 EARNINGS PER SHARE VIEW $2.89 -- THOMSON REUTERS I/B/E/S." DISAPPOINTED BY RECENT GOVERNMENT-INITIATED REIMBURSEMENT CUTS IN U.K."."GOVERNMENT-INITIATED REIMBURSEMENT CUTS IN U.K. CREATE ONGOING CHALLENGES IN OUR U.K. RETAIL PHARMACY BUSINESS".MCKESSON -Q1 GAAP LOSS PER SHARE INCLUDED PRE-TAX & AFTER-TAX NON-CASH GOODWILL IMPAIRMENT CHARGE OF $570 MILLION IN EUROPEAN PHARMACEUTICAL SOLUTIONS SEGMENT.  Full Article

McKesson Launches Multi-Year Strategic Growth Initiative; Reaffirms Fiscal 2018 Outlook
Wednesday, 25 Apr 2018 04:10pm EDT 

April 25 (Reuters) - McKesson Corp ::MCKESSON LAUNCHES MULTI-YEAR STRATEGIC GROWTH INITIATIVE; REAFFIRMS FISCAL 2018 OUTLOOK AND PROVIDES PRELIMINARY FISCAL 2019 OUTLOOK.REAFFIRMS FY 2018 ADJUSTED EARNINGS PER SHARE VIEW $12.50 TO $12.80.SEES FY 2019 ADJUSTED EARNINGS PER SHARE $13.00 TO $13.80.FY2018 EARNINGS PER SHARE VIEW $12.67 -- THOMSON REUTERS I/B/E/S.SIGNED A DEFINITIVE AGREEMENT TO ACQUIRE MEDICAL SPECIALTIES DISTRIBUTORS IN DEAL VALUED AT $800 MILLION.FY2019 EARNINGS PER SHARE VIEW $13.36 -- THOMSON REUTERS I/B/E/S.EXPECTS TRANSACTION WILL BE MODESTLY ACCRETIVE TO ADJUSTED EARNINGS PER DILUTED SHARE IN FISCAL 2019.MCKESSON - RESTRUCTURING PLAN CONSISTS OF AFTER-TAX GAAP CHARGES THAT ARE ESTIMATED TO BE APPROXIMATELY $150 MILLION TO $210 MILLION.INITIATIVE INCLUDES A COMPREHENSIVE REVIEW OF COMPANY'S OPERATIONS AND COST STRUCTURE.MCKESSON - INVESTMENT TO SUPPORT GROWTH INITIATIVES WILL BE PARTIALLY FUNDED BY SAVINGS FROM OPTIMIZATION OF CO'S OPERATING MODEL.  Full Article

McKesson Reports Q3 Adjusted Earnings Per Share $3.41
Thursday, 1 Feb 2018 07:00am EST 

Feb 1 (Reuters) - McKesson Corp ::MCKESSON REPORTS FISCAL 2018 THIRD-QUARTER RESULTS.SEES FY 2018 ADJUSTED EARNINGS PER SHARE $12.50 TO $12.80.Q3 ADJUSTED EARNINGS PER SHARE $3.41.Q3 GAAP EARNINGS PER SHARE $4.32 FROM CONTINUING OPERATIONS.Q3 REVENUE $53.6 BILLION VERSUS I/B/E/S VIEW $52.03 BILLION.SEES FY 2018 GAAP EARNINGS PER SHARE $7.65 TO $9.00 FROM CONTINUING OPERATIONS.Q3 EARNINGS PER SHARE VIEW $2.93 -- THOMSON REUTERS I/B/E/S.MCKESSON - QTRLY EARNINGS PER SHARE INCLUDED A NET TAX BENEFIT OF APPROXIMATELY $370 MILLION, OR $1.78, RELATED TO TAX CUTS AND JOBS ACT OF 2017.MCKESSON - RAISING AND NARROWING FISCAL 2018 ADJUSTED EARNINGS PER SHARE OUTLOOK FROM A RANGE OF $11.80 TO $12.50 TO NEW RANGE OF $12.50 TO $12.80.FY2018 EARNINGS PER SHARE VIEW $12.25 -- THOMSON REUTERS I/B/E/S.  Full Article

Atlassian Appoints James Beer As CFO
Monday, 18 Dec 2017 09:10am EST 

Dec 18 (Reuters) - Atlassian Corp Plc ::ATLASSIAN APPOINTS JAMES BEER AS CHIEF FINANCIAL OFFICER.ATLASSIAN CORP PLC - ‍ JAMES BEER WILL START AT ATLASSIAN ON FEBRUARY 20, 2018​.ATLASSIAN CORP PLC - ATLASSIAN'S CURRENT CFO MURRAY DEMO WILL LEAVE CO AT END OF JAN 2018.  Full Article

McKesson meets full-year profit estimates, renews partnership with CVS

U.S. drug distributor McKesson Corp forecast a full-year profit on Wednesday that matched analysts' estimates, easing some fears over drug pricing pressures and costs of opioid-related litigations.